As well as heart rate tracking it measures your blood oxygen, sleep, and VO2 Max for aerobic and cardio fitness ... down to hit the sweet spot of your anaerobic threshold. The downside, as ...

the cellular mechanisms behind its neuroprotective effects have remained elusive -- until now. This research highlights the potential for aerobic exercise to serve as a cornerstone in preventive ...

Swiss IoT module maker u-blox is to phase out its loss-making cellular IoT business, the firm has said. The division has over 200 employees; jobs are expected to go with its closure. It made revenue ...

u-blox Announces Strategic Decision to Increase Focus on Locate Business and Phase Out Cellular as well as an Impairment 14-Jan-2025 / 06:55 CET/CEST Release of an ad hoc announcement pursuant to Art.

Ookla’s assessment of cable MVNOs concludes that Xfinity and Spectrum customers have seen a 100-Mbps speed boost over the past two years Cellular customers of cable MVNOs Xfinity Mobile and Spectrum ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

(RTTNews) - Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...

Intra-Cellular Therapies (ITCI) shares soared 14.9% in the last trading session to close at $94.87. The move was backed by solid volume with far more shares changing hands than in a normal session.

J&J has offered to buy each share of Intra-Cellular for $132, representing a 39% premium to the stock's closing price on Friday. Shares of Intra-Cellular rose 34% to $128 in afternoon trading ...

Credit: Skorzewiak/Shutterstock. Johnson & Johnson (J&J) has announced it will acquire Intra-Cellular Therapies, a company specialising in central nervous system disorder treatments. The news was ...